Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 5, 2025BiomedicinesOpen Access

Clinical Utility of Multiplex Ligation-Dependent Probe Amplification in the Genetic Assessment of Patients with Myelodysplastic Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

RVRadostina ValevaDYDinnar YahyaIMIlina Micheva

Discussion

Loading...

Member takes

Overview

Analysis shows genetic abnormalities impact prognosis in MDS, suggesting MLPA can enhance risk stratification.

Key Points

  • MLPA effectively detected significant genetic abnormalities in myelodysplastic syndrome patients.
  • A chromosomal abnormality was found in 26.5% of cases, while JAK2 mutation occurred in 8.8%.
  • Bone marrow samples from 68 patients newly diagnosed with MDS were analyzed for genetic variations.
  • The presence of detected variants did not significantly correlate with overall survival in patients.

Cite This Study

Valeva et al. (2025) studied this question.

synapsesocial.com/papers/694022492d562116f28fbf0bhttps://doi.org/10.3390/biomedicines13122985
View Full Paper
Ask AI
Bookmark
Share